In July 2026, Doctolib, the dominant digital health platform in France, serving an estimated 50 to 60 million patients and over 80,000 healthcare professionals, initiated a nationwide notification campaign regarding the secondary reuse of patient health data for artificial intelligence research. This initiative formalises the establishment of the Doctolib AI Research Lab (Laboratoire de recherche en IA clinique), a private-public research venture structured to optimise care p